Metabolic Risk Factors in Cardiovascular Disease

David Maron serves as the C.F. Rehnborg Professor of Medicine at Stanford University School of Medicine, where he leads groundbreaking research in preventive cardiology as Chief of the Stanford Prevention Research Center. After completing his undergraduate studies at Stanford and medical degree from the University of Southern California, followed by residency at UCLA and fellowships at Stanford, he spent two decades at Vanderbilt before returning to Stanford in 2014. His distinguished career has been marked by leadership in landmark clinical trials, including the COURAGE trial and the ISCHEMIA trial, which have transformed the global management of stable coronary disease by emphasizing lifestyle modifications and medical therapy. As Director of Preventive Cardiology, he focuses on innovative approaches to early detection and prevention of coronary artery disease, including the development of AI algorithms for measuring calcified plaque in coronary arteries and investigating the use of noninvasive coronary CT angiograms. His current research explores transformative methods for preventing heart attacks, particularly in subclinical coronary disease. Board certified in internal medicine, cardiovascular disease, and clinical lipidology, Maron serves as president-elect of the American Society for Preventive Cardiology and continues to advance the field through his work at Stanford's Preventive Cardiology Clinic, where he combines clinical care with innovative research approaches to improve cardiovascular health outcomes.